• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

United States Oncology Drug Delivery Preferences and Opportunities in Cancer Drug Delivery - Volume 2: Patient Perspectives

  • ID: 2315177
  • November 2012
  • Region: United States
  • 103 Pages
  • Frost & Sullivan

Drug delivery is an important area of drug development in the pharmaceutical and biotechnology industry. In Oncology, developers are interested in understanding the opportunities and parameters for delivery of drugs in outpatient settings, particularly the home. This is important for biotechnology products used in this area as companies seek to design new products and evaluate new opportunities for targeted therapies and other cancer treatments. This research examines the awareness and utilization of oncology drug delivery methods, the perceptions, attitudes and willingness to use various methods, and the preference for and satisfaction with each method.


- Understand trends, dynamics, and parameters specific to the delivery of drugs to cancer patients in key treatment settings such as home, office, or infusion center.
- Identify physician prescribing trends relative to drug delivery considerations.
- Understanding the role of reimbursement in physician’s choice of drug delivery.
- Identify physicians’ perception of different drug delivery approaches, as well as key drivers for adoption/non-adoption, compliance, and choice of delivery devices.

Note: Product cover images may vary from those shown

1. Research Objectives and Methods

2. Executive Summary and Implications

3. Profile of Respondents

4. Awareness and Utilization of Oncology Drug Delivery Methods

5. Perceptions, Attitudes and Willingness to Use Drug Delivery Methods

6. Preference for and Satisfaction with Drug Delivery Methods

7. Preferred Setting for Treatment

8. Profile of Patients’ Compliance

9. Criteria of Drug Delivery Selection

10. The Frost & Sullivan Story

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown



Our Clients

Photocure ASA Roche Diagnostics Ltd. Abbott Laboratories Ltd. Pfizer, Inc. Novartis AG Becton, Dickinson and Company (BD)